Od redakcji PP: “Primum non nocere” – Hipokrates
Nastolatka w stanie Nevada w USA zapadła w śpiączkę, została podłączona pod respirator i przeszła 3 operacje mózgu, po tym jak wystąpiły zakrzepy 1 tydzień po otrzymaniu zastrzyku szczepionkowego firmy Johnson & Johnson (J&J).
A Nevada teen who received Johnson & Johnson’s (J&J) COVID vaccine on April 1 2021 underwent three brain surgeries to repair blood clots she developed about a week after receiving the vaccine, Las Vegas Review-Journal reported.
According to family spokesperson Bret Johnson, after Emma Burkey, 18, suffered seizures, doctors placed her in an induced coma and on a respirator. The high school senior has improved and is now awake and off the respirator, but still requires a tracheostomy tube, which has impaired her ability to speak.
“She is improving slowly,”
Johnson told Las Vegas Review-Journal.
“The word we got from her parents last night was ‘slowly, slowly slowly.’ For a while there, her situation and condition was completely unknown. Very scary and very iffy, honestly.”
Although Burkey experienced a “massive brain injury,” her parents are “cautiously optimistic,” Johnson said.
Burkey was first treated at St. Rose Dominican Hospital in Henderson before being airlifted to Loma Linda University Medical Center in Southern California for specialized care.
The woman, identified as 18-year-old Emma Burkey, was one of six women across the country who experienced a serious clotting side effect after receiving the one-shot vaccine.https://t.co/0yACTBhySQ
— FOX5 Las Vegas (@FOX5Vegas) April 20, 2021
A Centers for Disease Control and Prevention (CDC) panel said Burkey and other women experienced headaches and back pain prior to the discovery of blood clots.
The CDC panel also disclosed that Burkey was given heparin, a blood thinner which typically is standard treatment for blood clots, but in cases like Burkey’s, can actually make the condition worse.
“That would be a mistake in this situation because that could be dangerous and make the situation worse.”
U.S. health authorities recommended a pause for J&J vaccinations last week while they investigate reports of what they described as “rare and severe” clot conditions. The CDC’s Advisory Committee on Immunization Practices is scheduled to meet Friday to consider whether to resume vaccinations with J&J’s single-dose shot, and if so, what recommendations or restrictions for use should be put in place.
The European Medicines Agency said Tuesday its safety committee recommended a warning about a rare, serious blood-clot condition be added to the product information for J&J’s vaccine. The agency, which oversees drug regulation in the EU, said the benefits still outweigh the risks of the vaccine, but noted people should be aware of rare blood clot symptoms so they can quickly get treated if they develop symptoms.